Latest News & Features
Americas
US law firm Baker Donelson has expanded its Memphis office by hiring Cong Ding as of counsel in the firm’s intellectual property group. 30 October 2015
Americas
Pharmaceutical company Pfizer has confirmed it has entered into talks with generics company Allergan over a potential merger. 29 October 2015
Big Pharma
The English High Court has affirmed the validity of the Ono Pharmaceutical’s cancer immunotherapy drug after it was challenged by pharmaceutical company Merck. 29 October 2015
Biotechnology
There is “clearly a lot of unrest” in the patent law on molecular diagnostics, according to the head of licensing at Roche Diagnostics. 28 October 2015
Americas
The Coalition for Affordable Drugs, an organisation closely tied to hedge fund manager Kyle Bass, has persuaded the Patent Trial and Appeal Board to institute an inter partes review concerning the validity of two patents owned by biopharmaceutical company Celgene. 28 October 2015
Americas
Law firm Duane Morris has hired Paul Li as a partner in the firm’s intellectual property practice in San Francisco. 27 October 2015
Americas
Hedge fund manager Kyle Bass and his Coalition for Affordable Drugs have tasted success at the Patent Trial and Appeal Board for the second time in a month after it agreed to institute an inter partes review of a patent covering a drug owned by NPS Pharmaceuticals. 27 October 2015
Americas
US-based Vertex Pharmaceuticals and CRISPR Therapeutics have agreed a research collaboration to discover and develop new treatments for genetic causes of human diseases. 26 October 2015
Americas
Biotechnology company Luc Therapeutics has agreed to licence its intellectual property covering its depression treatment to Novartis, stating that it will accelerate its programme into how to help people living with psychiatric diseases. 23 October 2015
Americas
Very few members of Congress are informed about the trajectory of section 101 and instead lawmakers are looking at ‘trolls’ and other patent issues, according to a counsel at the Biotechnology Industry Organization. 23 October 2015